$PDEX
PRO DEX INC Stock $pdex

$pdex Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000107997324000181 Filed on February 08, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$14.29M	$12.59M
YoY Change	9.28%	11.58%
Cost Of Revenue	$10.29M	$9.786M
YoY Change	11.04%	13.02%
Gross Profit	$4.002M	$2.802M
YoY Change	5.01%	6.82%
Gross Profit Margin	28.0%	22.26%
Selling, General & Admin	$1.029M	$1.237M
YoY Change	-0.39%	21.39%
% of Gross Profit	25.71%	44.15%
Research & Development	$760.0K	$788.0K
YoY Change	6.59%	68.74%
% of Gross Profit	18.99%	28.12%
Depreciation & Amortization	$23.00K	$288.0K
YoY Change	-89.05%	50.79%
% of Gross Profit	0.57%	10.28%
Operating Expenses	$1.789M	$2.025M
YoY Change	2.46%	36.27%
Operating Profit	$2.213M	$777.0K
YoY Change	7.17%	-31.66%
Interest Expense	$138.0K	$139.0K
YoY Change	5.34%	8.59%
% of Operating Profit	6.24%	17.89%
Other Income/Expense, Net
YoY Change
Pretax Income	$913.0K	$620.0K
YoY Change	-48.36%	-47.19%
Income Tax	$258.0K	$120.0K
% Of Pretax Income	28.26%	19.35%
Net Earnings	$655.0K	$500.0K
YoY Change	-50.11%	-43.12%
Net Earnings / Revenue	4.58%	3.97%
Basic Earnings Per Share	$0.19	$0.14
Diluted Earnings Per Share	$0.19	$0.14
COMMON SHARES
Basic Shares Outstanding	3.511M shares	3.547M shares
Diluted Shares Outstanding	3.524K shares	3.612M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.339M	$8.601M
YoY Change	95.75%	165.3%
Cash & Equivalents	$3.219M	$1.289M
Short-Term Investments	$6.120M	$7.312M
Other Short-Term Assets	$1.403M	$1.313M
YoY Change	-26.89%	-21.09%
Inventory	$14.24M	$15.03M
Prepaid Expenses
Receivables	$12.52M	$13.17M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$35.96M	$36.60M
YoY Change	15.45%	16.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.191M	$5.331M
YoY Change	0.56%	2.46%
Goodwill
YoY Change
Intangibles	$61.00K	$68.00K
YoY Change	-29.89%	-30.61%
Long-Term Investments	$1.543M	$1.509M
YoY Change	0.59%	-12.57%
Other Assets	$42.00K	$42.00K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$14.59M	$14.83M
YoY Change	-7.83%	-8.43%
TOTAL ASSETS
Total Short-Term Assets	$35.96M	$36.60M
Total Long-Term Assets	$14.59M	$14.83M
Total Assets	$50.55M	$51.43M
YoY Change	7.61%	8.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.435M	$2.909M
YoY Change	11.96%	-13.53%
Accrued Expenses	$2.701M	$2.846M
YoY Change	11.38%	-14.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.858M	$3.846M
YoY Change	23.89%	23.67%
Total Short-Term Liabilities	$10.42M	$9.990M
YoY Change	2.71%	-14.36%
LONG-TERM LIABILITIES
Long-Term Debt	$7.884M	$8.228M
YoY Change	-14.74%	-14.2%
Other Long-Term Liabilities	$1.299M	$1.415M
YoY Change	-25.56%	-23.51%
Total Long-Term Liabilities	$9.191M	$9.651M
YoY Change	-16.38%	-15.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.42M	$9.990M
Total Long-Term Liabilities	$9.191M	$9.651M
Total Liabilities	$19.61M	$19.64M
YoY Change	-7.22%	-14.99%
SHAREHOLDERS EQUITY
Retained Earnings	$25.36M	$24.71M
YoY Change	31.73%	37.72%
Common Stock	$5.575M	$7.078M
YoY Change	-15.34%	8.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$30.94M	$31.79M
YoY Change
Total Liabilities & Shareholders Equity	$50.55M	$51.43M
YoY Change	7.61%	8.09%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$655.0K	$500.0K
YoY Change	-50.11%	-43.12%
Depreciation, Depletion And Amortization	$23.00K	$288.0K
YoY Change	-89.05%	50.79%
Cash From Operating Activities	$4.077M	$712.0K
YoY Change	74.38%	-280.25%
INVESTING ACTIVITIES
Capital Expenditures	$117.0K	$629.0K
YoY Change	-13.33%	23.58%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$1.250M
YoY Change		-125100.0%
Cash From Investing Activities	-$117.0K	-$1.879M
YoY Change	-13.33%	269.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.030M	560.0K
YoY Change	308.45%	-137.01%
NET CHANGE
Cash From Operating Activities	4.077M	712.0K
Cash From Investing Activities	-117.0K	-1.879M
Cash From Financing Activities	-2.030M	560.0K
Net Change In Cash	1.930M	-607.0K
YoY Change	13.13%	-74.88%
FREE CASH FLOW
Cash From Operating Activities	$4.077M	$712.0K
Capital Expenditures	$117.0K	$629.0K
Free Cash Flow	$3.960M	$83.00K
YoY Change	79.75%	-109.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0000788920
CY2023Q4	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2022Q4	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity		usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet		usd
	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	pdex	Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock		usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q4	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments		usd
CY2023Q4	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue		usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q4	pdex	Marketable Securities Warrant Non Current MarketableSecuritiesWarrantNonCurrent		usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-14942
	dei	Entity Registrant Name EntityRegistrantName	PRO-DEX, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1261240
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2361 McGaw Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92614
	dei	City Area Code CityAreaCode	(949)
	dei	Local Phone Number LocalPhoneNumber	769-3200
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	PDEX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3511253	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1289000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2936000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	5803000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	1134000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13169000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9952000	usd
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	412000	usd
CY2023Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	494000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	15026000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	16167000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	901000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	296000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	36600000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	30979000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6202000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6249000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5331000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5079000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1675000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1872000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	68000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	81000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	1509000	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	7521000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42000	usd
CY2023Q4	us-gaap	Assets Assets	51427000	usd
CY2023Q2	us-gaap	Assets Assets	51823000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2909000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2261000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2846000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3135000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	389000	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	453000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3846000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3827000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9990000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9676000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1415000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1638000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	8228000	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	8911000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9651000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10557000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	19641000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	20233000	usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3541045	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3541045	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3545309	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3545309	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7078000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	6767000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	24708000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	24823000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	31786000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31590000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51427000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51823000	usd
CY2023Q4	us-gaap	Revenues Revenues	12588000	usd
CY2022Q4	us-gaap	Revenues Revenues	11282000	usd
	us-gaap	Revenues Revenues	24526000	usd
	us-gaap	Revenues Revenues	22369000	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	9786000	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	8659000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	18066000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	16791000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	2802000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	2623000	usd
	us-gaap	Gross Profit GrossProfit	6460000	usd
	us-gaap	Gross Profit GrossProfit	5578000	usd
CY2023Q4	us-gaap	Selling Expense SellingExpense	37000	usd
CY2022Q4	us-gaap	Selling Expense SellingExpense	68000	usd
	us-gaap	Selling Expense SellingExpense	63000	usd
	us-gaap	Selling Expense SellingExpense	122000	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1200000	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	951000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2195000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1975000	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	788000	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	467000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1593000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1395000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	2025000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	1486000	usd
	us-gaap	Operating Expenses OperatingExpenses	3851000	usd
	us-gaap	Operating Expenses OperatingExpenses	3492000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	777000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1137000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2609000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2086000	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	139000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	128000	usd
	us-gaap	Interest Expense InterestExpense	271000	usd
	us-gaap	Interest Expense InterestExpense	258000	usd
CY2023Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-40000	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2740000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2593000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3165000	usd
CY2023Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	22000	usd
CY2022Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	7000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	46000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	225000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	7000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	620000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3756000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-209000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5225000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	120000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1004000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-94000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1270000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	500000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2752000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-115000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3955000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3547000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3574000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3547000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3595000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3612000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3652000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3547000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3672000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3541000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3554000	shares
	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3541000	shares
	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3554000	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31590000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	500000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2752000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-115000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3955000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	31786000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	28237000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	31786000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	28237000	usd
	us-gaap	Profit Loss ProfitLoss	-115000	usd
	us-gaap	Profit Loss ProfitLoss	3955000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	568000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	384000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	386000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	378000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2593000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3165000	usd
	pdex	Noncash Lease Expense Recovery NoncashLeaseExpenseRecovery	-7000	usd
	pdex	Noncash Lease Expense Recovery NoncashLeaseExpenseRecovery	1000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-4000	usd
	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	7000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	790000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3217000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3187000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-82000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	167000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1141000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2457000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	605000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	874000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	340000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	147000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-162000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-64000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	481000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1102000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2497000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1250000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	759000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	687000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	89000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2009000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-598000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	107000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1349000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	32000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	45000	usd
	pdex	Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock	-223000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1800000	usd
	pdex	Principal Payments On Notes Payable And Revolving Loan PrincipalPaymentsOnNotesPayableAndRevolvingLoan	2665000	usd
	pdex	Principal Payments On Notes Payable And Revolving Loan PrincipalPaymentsOnNotesPayableAndRevolvingLoan	2639000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-740000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2366000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1647000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-467000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2936000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	849000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1289000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382000	usd
	us-gaap	Interest Paid Net InterestPaidNet	272000	usd
	us-gaap	Interest Paid Net InterestPaidNet	257000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	658000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	841000	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2740000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2619000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3756000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1004000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2752000	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3165000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3139000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5225000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1270000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3955000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_zUUmOEAztp4e" style="font: bold 10pt Times New Roman, Times, Serif">NOTE 2.<span id="xdx_829_zAdPi9lhJVsi"> DESCRIPTION OF BUSINESS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We specialize in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adaptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> In August 2020, we formed a wholly owned subsidiary, PDEX Franklin, LLC (“PDEX Franklin”), to hold title for an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”) that we acquired on November 6, 2020, in order to allow for the continued growth of our business. The condensed consolidated financial statements include the accounts of the Company and PDEX Franklin and all significant inter-company accounts and transactions have been eliminated. This subsidiary has no separate operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	338000	usd
CY2022Q4	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	483000	usd
	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	528000	usd
	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	1391000	usd
CY2023Q4	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	12250000	usd
CY2022Q4	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	10799000	usd
	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	23998000	usd
	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	20978000	usd
CY2023Q4	us-gaap	Revenues Revenues	12588000	usd
CY2022Q4	us-gaap	Revenues Revenues	11282000	usd
	us-gaap	Revenues Revenues	24526000	usd
	us-gaap	Revenues Revenues	22369000	usd
CY2023Q4	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	usd
CY2022Q4	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	312000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	862000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	591000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	591000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	494000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	714000	usd
CY2023Q4	us-gaap	Accretion Expense AccretionExpense	107000	usd
CY2022Q4	us-gaap	Accretion Expense AccretionExpense	412000	usd
	us-gaap	Accretion Expense AccretionExpense	326000	usd
	us-gaap	Accretion Expense AccretionExpense	746000	usd
CY2023Q4	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	277000	usd
CY2022Q4	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	117000	usd
	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	382000	usd
	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	566000	usd
CY2023Q4	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	9000	usd
CY2022Q4	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	9000	usd
	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	26000	usd
	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	17000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	412000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	877000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	412000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	877000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	851000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1013000	usd
CY2022Q4	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	312000	usd
	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	43000	usd
	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	700000	usd
CY2022Q4	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	312000	usd
	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	43000	usd
	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	862000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	851000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	851000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	7524000	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	8824000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3905000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3686000	usd
CY2023Q4	pdex	Inventory Sub Assemblies InventorySubAssemblies	2721000	usd
CY2023Q2	pdex	Inventory Sub Assemblies InventorySubAssemblies	2387000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	876000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1270000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	15026000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	16167000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	5803000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	1134000	usd
CY2023Q2	pdex	Marketable Securities Warrant Non Current MarketableSecuritiesWarrantNonCurrent	6160000	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1509000	usd
CY2023Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1361000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	7312000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	8655000	usd
CY2023Q4	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	3964000	usd
CY2023Q2	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	2714000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	3300000	usd
	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	3800000	usd
	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	482000	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	219000	usd
CY2023	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	286000	usd
CY2023	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	67000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	763000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1134000	usd
CY2023Q4	us-gaap	Cash Cash	1250000	usd
CY2023Q4	pdex	Common Stock Shares CommonStockShares	1828551	shares
	pdex	Exercise Unrealized Loss Investment ExerciseUnrealizedLossInvestment	38000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	55000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	53000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	109000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	8000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	1000	usd
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	7000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	6499000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	6499000	usd
CY2023Q4	pdex	Accumulated Depreciation AccumulatedDepreciation	297000	usd
CY2023Q2	pdex	Accumulated Depreciation AccumulatedDepreciation	250000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6202000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6249000	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208000	usd
CY2023Q2	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	140000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	127000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	68000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	81000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	14000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	28000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	28000	usd
	pdex	Product Warranty Reserve ProductWarrantyReserve	194000	usd
CY2023	pdex	Product Warranty Reserve ProductWarrantyReserve	200000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	189000	usd
CY2022Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	365000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	200000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	340000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	29000	usd
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	14000	usd
CY2023Q4	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	32000	usd
CY2022Q4	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	77000	usd
	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	66000	usd
	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	119000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	194000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	344000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	194000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	344000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	64800	shares
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	500000	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2752000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-115000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3955000	usd
CY2023Q4	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3547000	shares
CY2022Q4	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3574000	shares
	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3547000	shares
	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3595000	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	500000	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2752000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-115000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3955000	usd
CY2023Q4	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3547000	shares
CY2022Q4	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3574000	shares
	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3547000	shares
	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3595000	shares
CY2023Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	65000	shares
CY2022Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	78000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	77000	shares
CY2023Q4	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3612000	shares
CY2022Q4	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3652000	shares
	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3547000	shares
	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3672000	shares
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	61000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	54000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y6M
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	435000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0553	pure
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	131000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	258000	usd
CY2022Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	127000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	250000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	261000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	535000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	551000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	567000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	143000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2057000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	207000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1850000	usd

Files In Submission

Name	View Source	Status
0001079973-24-000181-index-headers.html	Edgar Link	pending
0001079973-24-000181-index.html	Edgar Link	pending
0001079973-24-000181.txt	Edgar Link	pending
0001079973-24-000181-xbrl.zip	Edgar Link	pending
ex31z1.htm	Edgar Link	pending
ex31z2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pdex-20231231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pdex-20231231_cal.xml	Edgar Link	unprocessable
pdex-20231231_def.xml	Edgar Link	unprocessable
pdex-20231231_lab.xml	Edgar Link	unprocessable
pdex-20231231_pre.xml	Edgar Link	unprocessable
pdex_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pdex_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PDEX
PRO DEX INC Stock $pdex

2024 Q1 Form 10-Q Financial Statement

#000107997324000181 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX PRO DEX INC Stock $pdex

2024 Q1 Form 10-Q Financial Statement

#000107997324000181 Filed on February 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX
PRO DEX INC Stock $pdex